253 related articles for article (PubMed ID: 15709174)
1. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer.
Malik G; Ward MD; Gupta SK; Trosset MW; Grizzle WE; Adam BL; Diaz JI; Semmes OJ
Clin Cancer Res; 2005 Feb; 11(3):1073-85. PubMed ID: 15709174
[TBL] [Abstract][Full Text] [Related]
2. SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression.
Malik G; Rojahn E; Ward MD; Gretzer MB; Partin AW; Semmes OJ; Veltri RW
Prostate; 2007 Oct; 67(14):1565-75. PubMed ID: 17705230
[TBL] [Abstract][Full Text] [Related]
3. SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.
Skytt A; Thysell E; Stattin P; Stenman UH; Antti H; Wikström P
Int J Cancer; 2007 Aug; 121(3):615-20. PubMed ID: 17410539
[TBL] [Abstract][Full Text] [Related]
4. Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions.
Le L; Chi K; Tyldesley S; Flibotte S; Diamond DL; Kuzyk MA; Sadar MD
Clin Chem; 2005 Apr; 51(4):695-707. PubMed ID: 15695329
[TBL] [Abstract][Full Text] [Related]
5. Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma.
Wang X; Dai S; Zhang Z; Liu L; Wang J; Xiao X; He D; Liu B
Eur J Cancer Care (Engl); 2009 Nov; 18(6):625-35. PubMed ID: 19486127
[TBL] [Abstract][Full Text] [Related]
6. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
7. Detection and identification of potential biomarkers of non-small cell lung cancer.
Yang Y; Zhao S; Fan Y; Zhao F; Liu Q; Hu W; Liu D; Fan K; Wang J; Wang J
Technol Cancer Res Treat; 2009 Dec; 8(6):455-66. PubMed ID: 19925029
[TBL] [Abstract][Full Text] [Related]
8. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for determining prognosis in advanced stage hormone relapsing prostate cancer.
Kohli M; Siegel E; Bhattacharya S; Khan MA; Shah R; Suva LJ
Cancer Biomark; 2006; 2(6):249-58. PubMed ID: 17264396
[TBL] [Abstract][Full Text] [Related]
9. Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer.
Grizzle WE; Adam BL; Bigbee WL; Conrads TP; Carroll C; Feng Z; Izbicka E; Jendoubi M; Johnsey D; Kagan J; Leach RJ; McCarthy DB; Semmes OJ; Srivastava S; Srivastava S; Thompson IM; Thornquist MD; Verma M; Zhang Z; Zou Z
Dis Markers; 2003-2004; 19(4-5):185-95. PubMed ID: 15258333
[TBL] [Abstract][Full Text] [Related]
10. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.
Cazares LH; Adam BL; Ward MD; Nasim S; Schellhammer PF; Semmes OJ; Wright GL
Clin Cancer Res; 2002 Aug; 8(8):2541-52. PubMed ID: 12171882
[TBL] [Abstract][Full Text] [Related]
11. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
12. SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.
McLerran D; Grizzle WE; Feng Z; Thompson IM; Bigbee WL; Cazares LH; Chan DW; Dahlgren J; Diaz J; Kagan J; Lin DW; Malik G; Oelschlager D; Partin A; Randolph TW; Sokoll L; Srivastava S; Srivastava S; Thornquist M; Troyer D; Wright GL; Zhang Z; Zhu L; Semmes OJ
Clin Chem; 2008 Jan; 54(1):53-60. PubMed ID: 18024530
[TBL] [Abstract][Full Text] [Related]
13. MALDI-MS tissue imaging identification of biliverdin reductase B overexpression in prostate cancer.
Pallua JD; Schaefer G; Seifarth C; Becker M; Meding S; Rauser S; Walch A; Handler M; Netzer M; Popovscaia M; Osl M; Baumgartner C; Lindner H; Kremser L; Sarg B; Bartsch G; Huck CW; Bonn GK; Klocker H
J Proteomics; 2013 Oct; 91():500-14. PubMed ID: 23954705
[TBL] [Abstract][Full Text] [Related]
14. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
16. Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS.
Hegmans JP; Veltman JD; Fung ET; Verch T; Glover C; Zhang F; Allard WJ; T'Jampens D; Hoogsteden HC; Lambrecht BN; Aerts J
Technol Cancer Res Treat; 2009 Oct; 8(5):323-32. PubMed ID: 19754208
[TBL] [Abstract][Full Text] [Related]
17. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
18. The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.
Wang X; Han J; Hardie DB; Yang J; Borchers CH
J Mass Spectrom; 2016 Jan; 51(1):86-95. PubMed ID: 26757076
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of protein markers in serum and bronchoalveolar lavage fluid from patients with lung cancer by surface-enhanced laser desorption ionization time of flight mass spectrometry].
Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):274-7. PubMed ID: 21609611
[TBL] [Abstract][Full Text] [Related]
20. [Detection of serum biomarkers for retinoblastoma using surface enhanced laser desorption/ionization protein chip system].
Yang Y; Xiao X; Wu K; Wang J; Zhou L; Yang H; Li Y; He D; Zhang P
Yan Ke Xue Bao; 2007 Sep; 23(3):136-42. PubMed ID: 18041180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
